For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic ...

WEDNESDAY, March 12, 2025 (HealthDay News) -- Neoadjuvant semaglutide before metabolic and bariatric ... The researchers found that at postoperative months 6, 9, and 12, total weight loss (TWL ...

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent ...

This contrasts with previous studies that have found that taking semaglutide after surgery ... semaglutide before surgery had a higher percentage of total weight loss at three months than patients ...

In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic ...

Semaglutide use associated with increased risk for NAION at the 2-, 3-, and 4-year time point from the index date.

Patients who received semaglutide ... before MBS using nearest-neighbor propensity score matching (182 patients and 182 controls). The researchers found that at postoperative months 6, 9, and ...

Previous studies have found that taking semaglutide after weight loss surgery may ... found that patients who took the semaglutide before surgery had a higher percentage of total weight loss at three ...